MCU and breast carcinoma: Genetic silencing of MCU in the breast cancer cell line MDA-MB-231 reduced cell motility and invasiveness in vitro, as well as tumor growth, lymph node infiltration and lung metastasis in vivo (Tosatto et al., 2016).